ARMISTICE CAPITAL, LLC

Q2 2021 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
6/30/2021
Date filed
8/16/2021
Form type
13F-HR
Num holdings
116
Total value ($000)
$5,586,566
Net value change ($000)
+1,231,122 (28.3%)
New positions
32
Sold out positions
30
Turnover %
34.3%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

Prev filing: 5/17/2021 Next filing: 11/15/2021 SEC filing
You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q1 2021
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
IOVA 87,739 NEW
BURL 82,578 NEW
BIIB 46,859 58.2%
LULU 46,697 456.2%
TH 46,348 NEW
HOLX 42,167 NEW
HAE 41,583 NEW
WSM 41,059 NEW
ASO 38,160 NEW
VRTX 36,741 43.6%
Top Reduces (Value $000, Stocks/ETFs)
TJX -74,625 -100.0%
LNTH -57,699 -100.0%
AAP -50,179 -100.0%
NKE -42,856 -100.0%
RL -35,780 -100.0%
WMT -26,578 -46.3%
ADBE -25,670 -100.0%
TSCO -23,505 -100.0%
POST -19,875 -100.0%
Biohaven Pharmaceutical Holding Co Ltd. -19,810 -29.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 1,775,061 (31.8% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None